IRD Competitors & Alternatives
Compare Opus Genetics, Inc. with similar stocks in the same industry
Biotechnology
IRD
Main Stock$3.48
Tradestie Score
50
Market Cap
$107.83M
Revenue Growth
-0.5%
Analyst Upside
+203.3%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALT
Altimmune, Inc. Common Stock
|
$2.98
|
$341.56M | - | 57 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$6.50
|
$332.96M | - | 65 | Compare |
|
REPL
Replimune Group, Inc.
|
$9.68
|
$328.62M | - | 54 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.04
|
$319.22M | - | 54 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.63
|
$308.74M | - | 57 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.64
|
$304.12M | - | 57 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.86
|
$297.23M | - | 59 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$32.50
|
$293.03M | - | 58 | Compare |
|
OMER
Omeros Corporation
|
$10.37
|
$281.75M | 9.0 | 60 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.71
|
$275.54M | - | 57 | Compare |
More IRD Analysis
Data updated: Jul 15, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry